Cepheid said this week that it has appointed Peter Farrell as executive vice president of international commercial operations.
He replaces Philippe Jacon, whom the company had named head of worldwide commercial operations in January. Jacon is transitioning to the role of president of Cepheid's High-Burden Developing Country business, replacing Paul Steuperaert, who is now focusing on the company's business in sub-Saharan Africa ahead of his 2015 retirement.
Farrell most recently served as divisional vice president and general manager at Abbott Laboratories. Prior to this, he held a number of sales and marketing positions in Abbott's Diagnostics division.
DNA Electronics this week announced the appointment of Nick McCooke as chief business officer.
McCooke has previously served as CEO of Solexa, which was acquired by Illumina in 2007. There, he led the development of Solexa's next-generation sequencing technology, which is the basis of Illumina's current product line, DNAe said.